The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...

The four major Medicare parts (A, B, C, D) all offer some prescription drug coverage. Medicare Part D offers the most extensive outpatient prescription drug coverage ...

Story continues below this ad The minister said earlier there was only one template available to the world — the ... “As far as possible, minimum prescription has been kept in the rules to ensure ...

The minister said earlier there was only one template available to the world -- the European ... "As far as possible, minimum prescription has been kept in the rules to ensure simple implementation of ...

The minister said earlier there was only one template available to the world ... "As far as possible, minimum prescription has been kept in the rules to ensure simple implementation of the ...

Dr. Stephen Chin, interim vice president for medical affairs at Halton Healthcare, said health-care providers will need to register with PaRx to give out the prescription. After registering and ...

It was employed after it was translated into the Amharic version by a linguist to collect the relevant data from the patient prescription paper. The source of data was the hospital outpatient pharmacy ...